The Ernst Jung Prize for Medicine is awarded to researchers who have contributed considerably to progress in human medicine with their projects and are also expected to do so in future. SyNergy member Matthias Tschöp started his research more than 20 years ago to develop improved therapeutic compounds against the metabolic diseases obesity and diabetes, which reached pandemic dimensions all over the world.